Jan 31, 2020
Michelle Capobianco
Pancreatic Cancer Canada


Though the direct involvement of our Canadian friends, David & Liz Murray, we are honored to have the Chief Executive Officer of Pancreatic Cancer Canada, Ms. Michelle Capobianco, provide us with information on a joint Canada-U.S. research project. It involves the testing of new treatments on organoids grown from the tissue of current patients and may well mean a significant change for the better in how these patients’ cancers are treated.